Iranian Journal of Radiology

Published by: Kowsar

Relationship between the Computed Tomography - Measured Initial Primary Tumor Volume, Urine VMA Level and Stage in Neuroblastoma Patients

Chih - Chen Chang 1 , Shih - Hsiang Chen 2 , Tsung - Yen Chang 2 , Chao - Jan Wang 1 , Wendy Yang 3 , Chee - Jen Chang 4 and Tang - Her Jaing 2 , *
Authors Information
1 Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan, Taiwan
2 Department of Pediatrics, Division of Hematology/Oncology, Chang Gung Children’s Hospital, Linkou, Chang Gung University, Taoyuan, Taiwan
3 Department of Pediatric Surgery, Chang Gung Children’s Hospital, Linkou, Chang Gung University, Taoyuan, Taiwan
4 Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Article information
  • Iranian Journal of Radiology: July 2018, 15 (3); e63270
  • Published Online: June 11, 2018
  • Article Type: Research Article
  • Received: October 26, 2017
  • Revised: May 8, 2018
  • Accepted: May 16, 2018
  • DOI: 10.5812/iranjradiol.63270

To Cite: Chang C - C, Chen S - H, Chang T - Y, Wang C - J, Yang W, et al. Relationship between the Computed Tomography - Measured Initial Primary Tumor Volume, Urine VMA Level and Stage in Neuroblastoma Patients, Iran J Radiol. 2018 ; 15(3):e63270. doi: 10.5812/iranjradiol.63270.

Abstract
Copyright © 2018, Iranian Journal of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Suzuki K, Kohlbrenner R, Epstein ML, Obajuluwa AM, Xu J, Hori M. Computer-aided measurement of liver volumes in CT by means of geodesic active contour segmentation coupled with level-set algorithms. Med Phys. 2010;37(5):2159-66. doi: 10.1118/1.3395579. [PubMed: 20527550]. [PubMed Central: PMC2874039].
  • 2. Nishino M, Guo M, Jackman DM, DiPiro PJ, Yap JT, Ho TK, et al. CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool. Acad Radiol. 2011;18(1):54-62. doi: 10.1016/j.acra.2010.08.021. [PubMed: 21036632]. [PubMed Central: PMC3129593].
  • 3. Prasad SR, Jhaveri KS, Saini S, Hahn PF, Halpern EF, Sumner JE. CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology. 2002;225(2):416-9. doi: 10.1148/radiol.2252011604. [PubMed: 12409574].
  • 4. Haas-Kogan DA, Swift PS, Selch M, Haase GM, Seeger RC, Gerbing RB, et al. Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study. Int J Radiat Oncol Biol Phys. 2003;56(1):28-39. [PubMed: 12694821].
  • 5. Strenger V, Kerbl R, Dornbusch HJ, Ladenstein R, Ambros PF, Ambros IM, et al. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients. Pediatr Blood Cancer. 2007;48(5):504-9. doi: 10.1002/pbc.20888. [PubMed: 16732582].
  • 6. Barco S, Gennai I, Reggiardo G, Galleni B, Barbagallo L, Maffia A, et al. Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: report from the Italian Cooperative Group for Neuroblastoma. Clin Biochem. 2014;47(9):848-52. doi: 10.1016/j.clinbiochem.2014.04.015. [PubMed: 24769278].
  • 7. Rha SE, Byun JY, Jung SE, Chun HJ, Lee HG, Lee JM. Neurogenic tumors in the abdomen: tumor types and imaging characteristics. Radiographics. 2003;23(1):29-43. doi: 10.1148/rg.231025050. [PubMed: 12533638].
  • 8. Lonergan GJ, Schwab CM, Suarez ES, Carlson CL. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics. 2002;22(4):911-34. doi: 10.1148/radiographics.22.4.g02jl15911. [PubMed: 12110723].
  • 9. Morris JA, Shcochat SJ, Smith EI, Look AT, Brodeur GM, Cantor AB, et al. Biological variables in thoracic neuroblastoma: a Pediatric Oncology Group study. J Pediatr Surg. 1995;30(2):296-302. discussion 302-3. [PubMed: 7738754].
  • 10. Papaioannou G, McHugh K. Neuroblastoma in childhood: review and radiological findings. Cancer Imaging. 2005;5:116-27. doi: 10.1102/1470-7330.2005.0104. [PubMed: 16305949]. [PubMed Central: PMC1665241].
  • 11. London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, et al. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol. 2005;23(27):6459-65. doi: 10.1200/JCO.2005.05.571. [PubMed: 16116153].
  • 12. Trout AT, Towbin AJ, Klingbeil L, Weiss BD, von Allmen D. Single and multidimensional measurements underestimate neuroblastoma response to therapy. Pediatr Blood Cancer. 2017;64(1):18-24. doi: 10.1002/pbc.26159. [PubMed: 27440309].
  • 13. Miller TR, Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys. 2002;53(2):353-9. [PubMed: 12023139].
  • 14. Grabenbauer GG, Steininger H, Meyer M, Fietkau R, Brunner T, Heinkelmann P, et al. Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer. Radiother Oncol. 1998;47(2):175-83. [PubMed: 9683366].
  • 15. Vogl TJ, Trapp M, Schroeder H, Mack M, Schuster A, Schmitt J, et al. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology. 2000;214(2):349-57. doi: 10.1148/radiology.214.2.r00fe06349. [PubMed: 10671580].
  • 16. Imashuku S, Todo S, Nakajima F, Fujita K, Hibi S, Miyake M. Treatment for stage III-IV neuroblastoma patients: initial response to chemotherapy evaluated by biochemical parameters. Acta Paediatr Scand. 1991;80(10):924-30. [PubMed: 1755298].
  • 17. Hero B, Hunneman DH, Gahr M, Berthold F. Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma. Med Pediatr Oncol. 2001;36(1):220-3. doi: 10.1002/1096-911X(20010101)36:1<220::AID-MPO1053>3.0.CO;2-6. [PubMed: 11464889].
  • 18. Laug WE, Siegel SE, Shaw KN, Landing B, Baptista J, Gutenstein M. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma. Pediatrics. 1978;62(1):77-83. [PubMed: 683787].
  • 19. Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362(23):2202-11. doi: 10.1056/NEJMra0804577. [PubMed: 20558371]. [PubMed Central: PMC3306838].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments